Outcomes | DXM (n = 52) | N-DXM (n = 40) | P |
---|---|---|---|
Pain score on the second day | 3.60 ± 0.21 | 4.83 ± 0.32 | 0.001 |
Postoperative hospital stay, days | 6.21 ± 0.44 | 6.48 ± 0.36 | 0.658 |
Postoperative adverse events, n (%) | 0.313 | ||
Adverse cardiac events | 0 | 3 (7.5) | |
Adverse cerebrovascular events | 1 (1.9) | 0 | |
3-month follow-up, n (%) | 0.718 | ||
Type I endoleak | 0 | 1 (2.5) | |
Type II endoleak | 1 (1.9) | 1 (2.5) |